http://crossborderbiotech.ca/2009/09/24/mds-files-proxy-circular-for-sale-of-analytical-technologies-business-to-danaher/ Biotechnology, Health and Business in Canada, the United States and Worldwide Mon, 23 Aug 2010 02:23:29 +0000 hourly 1 http://wordpress.com/ http://crossborderbiotech.ca/2009/09/24/mds-files-proxy-circular-for-sale-of-analytical-technologies-business-to-danaher/comment-page-1/#comment-1049 Monday Biotech Deal Review: October 25, 2009 « The Cross-Border Biotech Blog Mon, 26 Oct 2009 11:03:03 +0000 http://crossborderbiotech.ca/?p=3225#comment-1049 [...] (TSX: MDS) (NYSE: MDZ) announced that over 99% of the Common Shares were voted in favour of the sale of its MDS Analytical Technologies business to Danaher Corporation (NYSE: DHR) for $650 million in cash.  MDS is also intent on selling its [...] [...] (TSX: MDS) (NYSE: MDZ) announced that over 99% of the Common Shares were voted in favour of the sale of its MDS Analytical Technologies business to Danaher Corporation (NYSE: DHR) for $650 million in cash.  MDS is also intent on selling its [...]

]]> http://crossborderbiotech.ca/2009/09/24/mds-files-proxy-circular-for-sale-of-analytical-technologies-business-to-danaher/comment-page-1/#comment-1019 Monday Biotech Deal Review: October 12, 2009 « The Cross-Border Biotech Blog Tue, 13 Oct 2009 03:05:15 +0000 http://crossborderbiotech.ca/?p=3225#comment-1019 [...] Inc. (TSX: MDS) (NYSE: MDZ) got a boost in its sale of its analytical technologies business, with leading proxy advisory firms (RiskMetrics Group, PROXY Governance Inc., and Glass, Lewis [...] [...] Inc. (TSX: MDS) (NYSE: MDZ) got a boost in its sale of its analytical technologies business, with leading proxy advisory firms (RiskMetrics Group, PROXY Governance Inc., and Glass, Lewis [...]

]]>